Date of Publication: 2.8.2018
Name of the diseases : Phase IIb trial in adult MPS VI ( Mucopolysacridosis ) patients
Name of the Drug: Odiparcil ( Odiparcil is a small molecule and can be taken orally. The drug was studied in a large number of clinical trials in another disease and was considered safe )
Duration: 24-week
Eligibility : for patients with MPS VI who are currently on Naglazyme and also for patients who are not taking Naglazyme.
Place: Test centers are located in Europe. Open fr Indian Patients and travel assistance is available .
For more information: https://www.
Name of the company : Inventiva (www.inventivapharma.com )
Additional Note: Company is also planning an Ib phase study for children with MPS VI. This SAFE KIDDS test will begin later this year. Followed by a comprehensive phase III study in all mentioned MPS diseases (MPS I, II, IVA, VI and VII).
Inventiva odiparcil 12 Jul 2018 An investigational new GAG clearance therapy for mucopolysaccharidosis I, II, IVA, VI and VII
